New Key Statistics Module, Z-Score and F-Score
NAS:TCRX Key Ratios
Market Cap $ M | 403.35 |
Enterprise Value $ M | 287.35 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.42 |
Price/Sales | 16.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 21.00 |
EPS (TTM) $ | -1.79 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.35 |
EV-to-EBITDA | -3.58 |
PEG | -- |
Shares Outstanding M | 52.86 |
Net Margin (%) | -423.86 |
Operating Margin % | -444.00 |
Pre-tax Margin (%) | -423.86 |
Quick Ratio | 6.51 |
Current Ratio | 6.51 |
ROA % (ttm) | -35.60 |
ROE % (ttm) | -64.85 |
ROIC % (ttm) | -99.85 |
Dividend Yield % | -- |
Altman Z-Score | 0.41 |
TCRX Number of Guru Trades
TCRX Volume of Guru Trades
Gurus Latest Trades with NAS:TCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TScan Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRX
Total 0- 1